The Skeleton You Don't Think About
Most people don't think about their bones until one breaks. This is understandable — healthy bones are invisible, painless, and easy to take for granted. But bone is living tissue, constantly being broken down and rebuilt in a process called remodeling. After the age of 30, the balance of this process gradually shifts: bone resorption begins to outpace bone formation, and bone density slowly declines.
For many adults, this decline is gradual and manageable. For others — particularly postmenopausal women and older men — it accelerates into osteoporosis: a condition in which bones become so porous and fragile that ordinary activities can cause fractures. A cough. A minor stumble. Bending to pick something up.
The tragedy of osteoporosis is that it is both silent and preventable. It causes no symptoms until a fracture occurs — and by then, significant bone loss has already taken place. This is precisely why screening matters.
Understanding Bone Loss: The Biology
Bone mass peaks in the late 20s to early 30s and then begins a slow, steady decline. The rate of loss is influenced by a range of factors:
- Sex hormones: Estrogen plays a critical role in maintaining bone density in women. At menopause, estrogen levels drop sharply, and bone loss accelerates dramatically — women can lose up to 20% of their bone density in the five to seven years following menopause. Men experience a more gradual decline in testosterone, which also contributes to bone loss, though typically at a slower rate.
- Calcium and vitamin D: Calcium is the primary mineral component of bone; vitamin D is essential for calcium absorption. Deficiency in either accelerates bone loss.
- Physical activity: Weight-bearing exercise stimulates bone formation. Sedentary lifestyles accelerate bone loss.
- Medications: Long-term use of corticosteroids (such as prednisone) is one of the most significant drug-related causes of bone loss. Proton pump inhibitors, anticonvulsants, and certain cancer treatments also affect bone metabolism.
- Body weight: Low body weight is associated with lower bone density; obesity is generally protective, though it carries its own risks.
- Smoking and alcohol: Both are independent risk factors for osteoporosis.
- Genetics: A family history of osteoporosis or fragility fractures significantly elevates personal risk.
The Scale of the Problem
Osteoporosis is far more common than most people realize. Globally, it is estimated to affect approximately 200 million women and a significant proportion of older men. In China, studies suggest that osteoporosis affects approximately 32% of women and 6% of men over the age of 50 — and that rates are rising as the population ages and sedentary urban lifestyles become more prevalent.
The consequences are serious. Osteoporotic fractures — particularly hip fractures — are associated with significant morbidity and mortality. Studies consistently show that approximately 20–30% of patients who sustain a hip fracture die within one year, often from complications such as pneumonia, deep vein thrombosis, or the general physiological stress of surgery and immobility in an older adult. Many survivors never regain their prior level of independence.
Vertebral compression fractures, another common consequence of osteoporosis, can cause chronic back pain, height loss, and a stooped posture (kyphosis) that affects breathing and quality of life.
The DEXA Scan: What It Is and What It Tells You
The gold standard for measuring bone mineral density (BMD) is the DEXA scan — dual-energy X-ray absorptiometry. It is fast (typically 10–20 minutes), painless, and uses a very low dose of radiation (far less than a standard chest X-ray). The scan measures bone density at the hip and lumbar spine — the two sites most relevant to fracture risk.
Results are reported as a T-score: the number of standard deviations above or below the average peak bone density of a healthy young adult of the same sex.
- T-score above −1.0: Normal bone density
- T-score between −1.0 and −2.5: Osteopenia (low bone density — a warning stage)
- T-score below −2.5: Osteoporosis
The DEXA result is often combined with the FRAX score — a validated tool developed by the World Health Organization that integrates bone density with clinical risk factors (age, sex, weight, prior fracture history, family history, smoking, alcohol use, and corticosteroid use) to estimate the 10-year probability of a major osteoporotic fracture. This combined assessment guides treatment decisions more accurately than bone density alone.
Who Should Be Screened — and When
Current international guidelines generally recommend DEXA screening for:
- All women aged 65 and older
- Postmenopausal women under 65 with one or more risk factors (family history, low body weight, prior fracture, smoking, corticosteroid use)
- Men aged 70 and older
- Men aged 50–69 with significant risk factors
- Any adult who has sustained a fragility fracture (a fracture from a fall from standing height or less)
- Adults on long-term corticosteroid therapy
In practice, many physicians recommend initiating a baseline DEXA scan for women at menopause (typically around age 50) and for men at age 60–65, with earlier screening for those with risk factors. If the baseline scan is normal and risk factors are low, repeat scanning every two years is generally sufficient.
Osteopenia: The Warning Stage
A diagnosis of osteopenia — bone density that is below normal but not yet in the osteoporotic range — is not a cause for alarm, but it is a call to action. Osteopenia does not inevitably progress to osteoporosis, and with appropriate intervention, progression can be slowed or halted.
Interventions at the osteopenia stage typically focus on lifestyle modification: adequate calcium and vitamin D intake, regular weight-bearing and resistance exercise, smoking cessation, and moderation of alcohol. Pharmacological treatment (bisphosphonates or other bone-protective agents) is generally reserved for those with osteoporosis or a high FRAX score, though this varies by individual circumstances.
Joint Health: The Other Side of Musculoskeletal Aging
Alongside bone density, joint health is a critical and often neglected component of musculoskeletal screening in middle-aged adults. Osteoarthritis — the degenerative joint disease characterized by the breakdown of cartilage — is the most common form of arthritis globally and affects an estimated 500 million people worldwide.
Osteoarthritis develops gradually, often beginning in the 40s and 50s, and most commonly affects the knees, hips, hands, and spine. In its early stages, it may cause only mild stiffness or discomfort after periods of inactivity. As it progresses, it can cause significant pain, reduced range of motion, and functional limitation.
There is no cure for osteoarthritis, but early identification allows for interventions that can slow progression and preserve function: weight management (each kilogram of body weight reduction reduces knee joint load by approximately four kilograms), targeted physiotherapy, appropriate exercise, and in some cases, joint-protective medications or injections.
Imaging — X-ray for established disease, MRI for early cartilage assessment — can quantify the degree of joint degeneration and guide management decisions.
Vitamin D: The Overlooked Deficiency
Vitamin D deficiency is remarkably common in adults worldwide — including in sunny climates — and has significant implications for both bone health and broader health outcomes. Vitamin D is essential for calcium absorption in the gut; without adequate vitamin D, even a calcium-rich diet cannot maintain bone density effectively.
Beyond bone health, vitamin D receptors are present in virtually every tissue in the body, and deficiency has been associated with increased risk of cardiovascular disease, autoimmune conditions, certain cancers, and impaired immune function. A simple blood test (serum 25-hydroxyvitamin D) can identify deficiency, and supplementation is safe, inexpensive, and effective.
Serum vitamin D testing should be a routine component of any comprehensive health checkup for adults over 40, particularly for those who spend limited time outdoors, have darker skin pigmentation, or live at higher latitudes.
Putting It Together: A Musculoskeletal Health Assessment
A comprehensive musculoskeletal health assessment for adults over 50 should include:
- DEXA bone density scan with FRAX score calculation
- Serum calcium, phosphate, and 25-hydroxyvitamin D
- Parathyroid hormone (PTH) if calcium or vitamin D abnormalities are found
- Clinical assessment of joint symptoms and range of motion
- Imaging of symptomatic joints (X-ray as first line; MRI if indicated)
- Muscle strength and balance assessment (particularly relevant for fall risk in adults over 65)
A Note for International Patients in Shanghai
DEXA scanning and comprehensive musculoskeletal assessments are readily available at Shanghai's leading hospitals. For international patients who want to include bone density and joint health screening as part of a broader health checkup, China Medical Concierge Shanghai (CMCS) can help coordinate the appropriate tests and connect you with the right specialists — with full language support throughout.
0 Kommentare